FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2119635842> ?p ?o ?g. }

• W2119635842 endingPage "2097" @default.
• W2119635842 startingPage "2089" @default.
• W2119635842 abstract "Human papillomavirus type 16 (HPV-16)-associated vulval intraepithelial neoplasia (VIN) is frequently a chronic, multifocal high-grade condition with an appreciable risk of progression to vulval cancer. The requirement to treat women with VIN has recently stimulated the use of immunotherapy with E6/E7 oncogene vaccines. Animal models have shown that E2 may also be a useful vaccine target for HPV-associated disease; however, little is known about E2 immunity in humans. This study investigated the prevalence of HPV-16 E2-specific serological and T-cell responses in 18 women with HPV-16-associated VIN and 17 healthy volunteers. E2 responses were determined by full-length E2–GST ELISA with ELISPOT and proliferation assays using E2 C-terminal protein. As positive controls, HPV-16 L1 responses were measured using virus-like particles (VLPs) and L1–GST ELISA with ELISPOT and proliferation using VLPs as antigen. The VIN patients all showed a strong serological response to L1 compared with the healthy volunteers by VLP (15/18 vs 1/17, P<0·001) and L1–GST ELISA (18/18 vs 1/17, P<0·001). In contrast, L1-specific cellular immune responses were detected in a significant proportion of controls but were more prevalent in the VIN patients by proliferation assay (9/17 vs 17/18, P<0·02) and interferon-γ ELISPOT (9/17 vs 13/18, P=not significant). Similar and low numbers of patients and controls were seropositive for E2-specific Ig (2/18 vs 1/17). In spite of previous studies showing the immunogenicity of E2 in eliciting primary T-cell responses in vitro, there was a low prevalence of E2 responses in the VIN patients and controls (2/18 vs 0/17)." @default.
• W2119635842 created "2016-06-24" @default.
• W2119635842 creator A5001242288 @default.
• W2119635842 creator A5008419054 @default.
• W2119635842 creator A5012232754 @default.
• W2119635842 creator A5035157190 @default.
• W2119635842 creator A5049385540 @default.
• W2119635842 creator A5075610233 @default.
• W2119635842 creator A5082838037 @default.
• W2119635842 creator A5082997520 @default.
• W2119635842 creator A5090535914 @default.
• W2119635842 date "2003-08-01" @default.
• W2119635842 modified "2023-10-02" @default.
• W2119635842 title "Human papillomavirus type 16 E2- and L1-specific serological and T-cell responses in women with vulval intraepithelial neoplasia" @default.
• W2119635842 cites W1489188497 @default.
• W2119635842 cites W1518785179 @default.
• W2119635842 cites W1807715620 @default.
• W2119635842 cites W1859510236 @default.
• W2119635842 cites W1968443594 @default.
• W2119635842 cites W1975519033 @default.
• W2119635842 cites W1981480494 @default.
• W2119635842 cites W1986355149 @default.
• W2119635842 cites W1987958334 @default.
• W2119635842 cites W1995648581 @default.
• W2119635842 cites W2001980141 @default.
• W2119635842 cites W2003431268 @default.
• W2119635842 cites W2013834971 @default.
• W2119635842 cites W2022792317 @default.
• W2119635842 cites W2026599341 @default.
• W2119635842 cites W2036069120 @default.
• W2119635842 cites W2038070129 @default.
• W2119635842 cites W2047675824 @default.
• W2119635842 cites W2054699629 @default.
• W2119635842 cites W2065298839 @default.
• W2119635842 cites W2067470968 @default.
• W2119635842 cites W2068183346 @default.
• W2119635842 cites W2068397052 @default.
• W2119635842 cites W2075440912 @default.
• W2119635842 cites W2088288551 @default.
• W2119635842 cites W2101032551 @default.
• W2119635842 cites W2120637872 @default.
• W2119635842 cites W2123905003 @default.
• W2119635842 cites W2129106917 @default.
• W2119635842 cites W2134310125 @default.
• W2119635842 cites W2142680679 @default.
• W2119635842 cites W2152156910 @default.
• W2119635842 cites W2152820745 @default.
• W2119635842 cites W2153700326 @default.
• W2119635842 cites W2154409769 @default.
• W2119635842 cites W2159636033 @default.
• W2119635842 cites W2160670069 @default.
• W2119635842 cites W2166010149 @default.
• W2119635842 cites W3143504308 @default.
• W2119635842 cites W4362208337 @default.
• W2119635842 doi "https://doi.org/10.1099/vir.0.19095-0" @default.
• W2119635842 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/12867639" @default.
• W2119635842 hasPublicationYear "2003" @default.
• W2119635842 type Work @default.
• W2119635842 sameAs 2119635842 @default.
• W2119635842 citedByCount "23" @default.
• W2119635842 countsByYear W21196358422012 @default.
• W2119635842 countsByYear W21196358422013 @default.
• W2119635842 countsByYear W21196358422014 @default.
• W2119635842 countsByYear W21196358422015 @default.
• W2119635842 countsByYear W21196358422016 @default.
• W2119635842 crossrefType "journal-article" @default.
• W2119635842 hasAuthorship W2119635842A5001242288 @default.
• W2119635842 hasAuthorship W2119635842A5008419054 @default.
• W2119635842 hasAuthorship W2119635842A5012232754 @default.
• W2119635842 hasAuthorship W2119635842A5035157190 @default.
• W2119635842 hasAuthorship W2119635842A5049385540 @default.
• W2119635842 hasAuthorship W2119635842A5075610233 @default.
• W2119635842 hasAuthorship W2119635842A5082838037 @default.
• W2119635842 hasAuthorship W2119635842A5082997520 @default.
• W2119635842 hasAuthorship W2119635842A5090535914 @default.
• W2119635842 hasBestOaLocation W21196358421 @default.
• W2119635842 hasConcept C121608353 @default.
• W2119635842 hasConcept C126322002 @default.
• W2119635842 hasConcept C147483822 @default.
• W2119635842 hasConcept C159047783 @default.
• W2119635842 hasConcept C159654299 @default.
• W2119635842 hasConcept C203014093 @default.
• W2119635842 hasConcept C2776090121 @default.
• W2119635842 hasConcept C2777343196 @default.
• W2119635842 hasConcept C2777701055 @default.
• W2119635842 hasConcept C2778220009 @default.
• W2119635842 hasConcept C2779053233 @default.
• W2119635842 hasConcept C2781076405 @default.
• W2119635842 hasConcept C2994532551 @default.
• W2119635842 hasConcept C45189115 @default.
• W2119635842 hasConcept C71924100 @default.
• W2119635842 hasConcept C86803240 @default.
• W2119635842 hasConcept C8891405 @default.
• W2119635842 hasConceptScore W2119635842C121608353 @default.
• W2119635842 hasConceptScore W2119635842C126322002 @default.
• W2119635842 hasConceptScore W2119635842C147483822 @default.
• W2119635842 hasConceptScore W2119635842C159047783 @default.
• W2119635842 hasConceptScore W2119635842C159654299 @default.

• next